Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study

The Lancet HIV

Volumn 4, Issue 10, 2017, Pages e442-e448

  Technau, Karl Günter ^a   Kuhn, Louise ^b   Coovadia, Ashraf ^a   Murnane, Pamela M ^a,b   Sherman, Gayle ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Vagelos College of Physicians and Surgeons   (United States)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRAL THERAPY; APGAR SCORE; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL CHILD HEALTH CARE; NEWBORN; NEWBORN SCREENING; PHLEBOTOMY; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; ADULT; DEVICES; DIAGNOSTIC KIT; EVALUATION STUDY; GENETICS; HOSPITAL; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MOTHER; PREGNANCY; PROCEDURES; STANDARDS; TRANSMISSION; VERTICAL TRANSMISSION; YOUNG ADULT;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HOSPITALS, MATERNITY; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; NEONATAL SCREENING; POINT-OF-CARE TESTING; PREGNANCY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85023763493     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(17)30097-8     Document Type: Article

References (31)

1. Bourne, DE, Thompson, M, Brody, LL, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS 23 (2009), 101–106.
2. Marston, M, Becquet, R, Zaba, B, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 40 (2011), 385–396.
3. Innes, S, Lazarus, E, Otwombe, K, et al. Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?. J Int AIDS Soc, 17, 2014, 18914.
4. National Department of Health. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults, 2015 edn., 2015, National Department of Health, Pretoria.
5. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection—recommendations for a public health approach, 2nd edn., 2016, World Health Organization, Geneva.
6. Wagner, A, Slyker, J, Langat, A, et al. High mortality in HIV-infected children diagnosed in hospital underscores need for faster diagnostic turnaround time in prevention of mother-to-child transmission of HIV (PMTCT) programs. BMC Pediatr, 15, 2015, 10.
7. Essajee, S, Vojnov, L, Penazzato, M, et al. Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. J Int AIDS Soc, 18, 2015, 20299.
8. Day, C, Barron, P, Massyn, N, Padarath, A, English, R, District Health Barometer 2010/11, 2011, Health Systems Trust, South Africa.
9. National Department of Health. The 2013 National Antenatal Sentinel HIV Prevalence Survey South Africa, 2015 ed., 2015, National Department of Health, Pretoria.
10. Ciaranello, AL, Park, JE, Ramirez-Avila, L, Freedberg, KA, Walensky, RP, Leroy, V, Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med, 9, 2011, 59.
11. Scott, L, Gous, N, Carmona, S, Stevens, W, Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa. J Clin Microbiol 53 (2015), 1616–1621.
12. Ritchie, AV, Goel, N, Sembongi, H, et al. Performance evaluation of the point-of-care SAMBA I and II HIV-1 Qual whole blood tests. J Virol Methods 237 (2016), 143–149.
13. Mtapuri-Zinyowera S, Ndlovu Z, Farjado E, et al. Diagnostic accuracy of Cepheid Xpert HIV-1 Qual for early infant diagnosis. Conference on Retroviruses and Opportunistic Infections; Boston, MA, USA; Feb 22–25, 2016. Abstract 787.
14. Murray T, Carmona S, Nakwa F, et al. Paediatric HIV point of care testing: field evaluation of the performance of Cepheid and Alere Qualitative HIV Assays in a Soweto academic hospital. 8th International Workshop on HIV Pediatrics; Durban, South Africa; July 15–16, 2016. Abstract O_08.
15. Jani, IV, Meggi, B, Mabunda, N, et al. Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr 67 (2014), e1–e4.
16. Hsiao, NY, Dunning, L, Kroon, M, Myer, L, Laboratory evaluation of the Alere q point-of-care system for early infant HIV diagnosis. PLoS One, 11, 2016, e0152672.
17. Kroon M, Dunning L, Hsiao M, Myer L. Field evaluation of point-of-care testing for early infant diagnosis in Cape Town, South Africa. 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015); Vancouver, BC, Canada; July 19–22, 2015. Abstract MOAB0101.
18. Carmona S, Wedderburn C, Macleod W, et al. Field performance of point-of-care HIV testing for early infant diagnosis: pooled analysis from six countries from the EID Consortium. 21st International AIDS Conference; Durban, South Africa; July 18–22, 2016. Abstract LBPE008.
19. Technau, K, Can a routine peri-partum HIV counselling and testing service for women improve access to HIV prevention, early testing and treatment of children? [dissertation], 2009, University of the Witwatersrand, Johannesburg, South Africa.
20. Apgar, V, A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 32 (1953), 260–267.
21. WHO. WHO list of prequalified in vitro diagnostic products. http://www.who.int/diagnostics_laboratory/evaluations/PQ_list/en/, 2016 (accessed Aug 16, 2016).
22. Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG, Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
23. Luzuriaga, K, Tabak, B, Garber, M, et al. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210 (2014), 1529–1538.
24. Persaud, D, Gay, H, Ziemniak, C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 369 (2013), 1828–1835.
25. Rainwater-Lovett, K, Uprety, P, Persaud, D, Advances and hope for perinatal HIV remission and cure in children and adolescents. Curr Opin Pediatr 28 (2016), 86–92.
26. Shannon, M, Lee, KA, HIV-infected mothers' perceptions of uncertainty, stress, depression and social support during HIV viral testing of their infants. Archives of women's mental health 11 (2008), 259–267.
27. Shannon, M, Kennedy, HP, Humphreys, JC, HIV-infected mothers' foci of concern during the viral testing of their infants. JANAC 19 (2008), 114–126.
28. Varga, CA, Sherman, GG, Maphosa, J, Jones, SA, Psychosocial consequences of early diagnosis of HIV status in vertically exposed infants in Johannesburg, South Africa. Health Care Women Int 26 (2005), 387–397.
29. Fonjungo, PN, Osmanov, S, Kuritsky, J, et al. Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programs. AIDS 30 (2016), 1317–1323.
30. WHO. WHO prequalification of in vitro diagnostics public report. Product: XPert® HIV-1 Qual Assay. WHO reference number: PQDx 0259-070-00, 2016, World Health Organization, Geneva http://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/160613PQPublicReport_0259-0700-00_XpertQualHIV_v2.pdf (accessed Sept 10, 2016).
31. Fonjungo, PN, Boeras, DI, Zeh, C, Alexander, H, Parekh, BS, Nkengasong, JN, Access and quality of HIV-related point-of-care diagnostic testing in global health programs. Clin Infect Dis 62 (2016), 369–374.